Package 0904-6636-61

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0904-6636-61
Digits Only 0904663661
Product NDC 0904-6636
Product ID 0904-6636_9e06ea08-4c71-4904-84ce-257d949b3679
Description

100 BLISTER PACK in 1 CARTON (0904-6636-61) / 1 TABLET, FILM COATED in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2006-01-17
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "9e06ea08-4c71-4904-84ce-257d949b3679", "openfda": {"unii": ["ZG7E5POY8O"], "spl_set_id": ["b127d3fc-be5e-4c12-8026-205766bf8e7f"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-6636-61)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0904-6636-61", "marketing_start_date": "20060117"}], "brand_name": "Bupropion Hydrochloride", "product_id": "0904-6636_9e06ea08-4c71-4904-84ce-257d949b3679", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0904-6636", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA076143", "marketing_category": "ANDA", "marketing_start_date": "20060117", "listing_expiration_date": "20271231"}